Skip to main content
. Author manuscript; available in PMC: 2019 Feb 16.
Published in final edited form as: ACS Chem Biol. 2018 Jan 25;13(2):366–375. doi: 10.1021/acschembio.7b00965

Figure 2.

Figure 2

Schematic of combined CRISPRi/a screens.

A: Schematic of pooled CRISPRi and CRISPRa screens for drug sensitivity. Other pooled screens can be conducted analogously using the corresponding cell lines and libraries.

B: Comparing knockdown and overexpression data such as those from combined CRISPRi and CRISPRa screens reveals genes with anti-correlated sensitivity phenotypes. These genes are likely to be directly involved in the pathway targeted by the drug.